SCD‐plus features and AD biomarkers in cognitively unimpaired samples: A meta‐analytic approach for nine cohort studies is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Deutsches Zentrum für Neurodegenerative Erkrankungen
Grant: BN012
U.S. Department of Defense
Grant: W81XWH‐12‐2‐0012
National Institute on Aging
Grant: DP2AG082342
Helmholtz Artificial Intelligence Cooperation Unit
Grant: ZT‐I‐PF‐5‐163
Instituto de Salud Carlos III
Grant: CP23/00039
Alzheimer's Association
Grant: IIRG‐08‐88733
NIA NIH HHS
Grant: K99 AG061238
NIA NIH HHS
Grant: R01 AG034962
National Institutes of Health/National Institute on Aging (NIH/NIA)
Grant: U24AG057437
NIH-NCATS
Grant: UL1TR000427
NIA NIH HHS
Grant: K23 AG045966
NIA NIH HHS
Grant: R01 AG027161
NIA NIH HHS
Grant: R01 AG062826
NCATS NIH HHS
Grant: UL1 TR000445
NCATS NIH HHS
Grant: UL1 TR002373
Alzheimer's Association
Grant: IIRG-08-88733
National Institutes of Health/National Institute on Aging (NIH/NIA)
Grant: P01AG036694
National Institutes of Health/National Institute on Aging (NIH/NIA)
Grant: R01-AG079142
NIA NIH HHS
Grant: U19 AG010483
National Institutes of Health/National Institute on Aging (NIH/NIA)
Grant: K23-AG045966
NIA NIH HHS
Grant: U01 AG024904
U.S. Department of Defense
Grant: W81XWH-12-2-0012
PHRCN
Grant: 2011-A01493-38
NIA NIH HHS
Grant: R00 AG061238
NIA NIH HHS
Grant: R01 AG063689
NIA NIH HHS
Grant: R01 AG079142
National Institutes of Health/National Institute on Aging (NIH/NIA)
Grant: R01-AG062826
NIA NIH HHS
Grant: RF1 AG027161
National Institutes of Health/National Institute on Aging (NIH/NIA)
Grant: R00-AG061238
National Institutes of Health/National Institute on Aging (NIH/NIA)
Grant: R01-AG027161
Helmholtz Artificial Intelligence Cooperation Unit
Grant: ZT-I-PF-5-163
PHRCN
Grant: 2012-12-006-0347
National Institutes of Health/National Institute on Aging (NIH/NIA)
Grant: R01-AG063689
National Institutes of Health
Grant: 6UL1TR000445-11
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 1R01AG027161-01A2
Wisconsin Registry for Alzheimer Prevention: Biomarkers of Preclinical AD
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1DP2AG082342-01
The inactive X: discovering sex genes that influence female vulnerability to Alzheimer's disease
National Institutes of Health
Grant: 3U19AG010483-26S4
Alzheimer's Disease Cooperative Study
National Institutes of Health
Grant: 5R01AG034962-09
Vanderbilt Memory & Aging Project
National Institutes of Health
Grant: 1R01AG079142-01A1
Building predictive algorithms to identify resilience and resistance to Alzheimer's disease
National Institutes of Health
Grant: 3U24AG057437-02S1
Alzheimers Clinical Trials Consortium (ACTC)
National Institutes of Health
Grant: 5R00AG061238-04
Sex differences in the progression of Alzheimer's disease: is menopause the key?
National Institutes of Health
Grant: 5R01AG062826-02
Subjective Cognitive Decline in OIder Adults
National Institutes of Health
Grant: 5UL1TR000427-08
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 5R01AG063689-02
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
National Institutes of Health
Grant: 3P01AG036694-09S2
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study
National Institutes of Health
Grant: 6K23AG045966-02
Cognitive Complaints in Aging Adults
AVID
BioClinica
BioClinica, Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd and Genentech, Inc.
GE Healthcare
Lumosity
National Ageing Research Institute
NeuroRx Research
Foundation for the National Institutes of Health
INSERM
Piramal Imaging
Alzheimer's Therapeutic Research Institute, University of Southern California
Eisai Inc.
Fondation Philippe Chatrier
GHR Foundation
H. Lundbeck A/S
Meso Scale Diagnostics, LLC
Neurotrack Technologies
Servier
Takeda Pharmaceutical Company
University Caen Normandy
Albert Einstein College of Medicine, Yeshiva University
Alzheimer's Drug Discovery Foundation
Biogen
Bristol-Myers Squibb Company
CIHR
Davis Alzheimer Prevention Program
Edith Cowan University
Florey Institute, The University of Melbourne
NIBIB NIH HHS
Transition Therapeutics
Alzheimer's Drug Discovery Foundation
Araclon Biotech
Association France Alzheimer et maladies apparentées (AAP 2013)
Austin Health
Brigham and Women's Hospital
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Dioraphte and the Noaber Foundation
Foundation for Neurologic Disease
Fujirebio Europe
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC
Lundbeck
Northern California Institute for Research and Education
Pfizer
Région Basse Normandie
AbbVie
Cogstate
Merck & Co., Inc.
Agence Nationale de la Recherche (ANR LONGVIE 2007)
Canadian Institutes of Health Research
CereSpir, Inc.
European Union, FSE+
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Albert Einstein College of Medicine
Bristol-Myers Squibb
EuroImmun
Fondation Plan Alzheimer (Alzheimer Plan 2008-2012)
Fujirebio
Johnson & Johnson Pharmaceutical Research & Development LLC
Laboratory for Neuro Imaging, University of Southern California
Merck
National Institute of Biomedical Imaging and Bioengineering
Pasman Chair
FWCI
9.09
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals